US$ 27.83
does semaglutide cause birth defects Impact of exposure on fetal and neonatal outcomes in pregnant women: a systematic review What to know about weight
Description
Final MRP: 3,200 - 3,800 per month

doi: 10.1073/pnas.94.26.14942

(The $199 per month offer is only available for a limited time, new patients, and for certain doses.) Unfortunately, Wegovy isn't part of Novo Nordisks patient assistance program

Semaglutide (Ozempic) is a GLP-1 receptor agonist licensed in the UK for type 2 diabetes management, administered via pre-filled subcutaneous injection pen
Your doctor may need to adjust the timing or dosage of your other drugs
